Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx
SHANGHAI, May 22, 2015 /PRNewswire/ -- A consortium ("the Consortium") consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China Everbright Limited's healthcare fund ("CEL Healthcare Fund"), and WuXi PharmaTech announced today that the Consortium has sign...
WuXi PharmaTech Announces First-Quarter 2012 Results
SHANGHAI, May 10, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results...
WuXi PharmaTech Files 2011 Annual Report on Form 20-F
SHANGHAI, April 20, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2011 with the Securities and Exchange Commission. The annual report can be accessed on WuXi PharmaTech's website at http...
WuXi PharmaTech Schedules First-Quarter 2012 Earnings Release
SHANGHAI, April 17, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the first quarter ...
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2011 Results, Share Repurchase Program
SHANGHAI, March 8, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial result...
WuXi PharmaTech Announces Purchase of Ordinary Shares from General Atlantic
SHANGHAI, Feb. 15, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, with operations in China and the United States, announced that today it had in a negotiated transaction agreed to purchas...
WuXi PharmaTech Schedules Fourth-Quarter 2011 Earnings Release
SHANGHAI, Feb. 8, 2012 /PRNewswire-Asia / -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the fourth quarter ...
WuXi PharmaTech Announces Third-Quarter 2011 Results
SHANGHAI, Nov. 10, 2011 /PRNewswire-Asia/ -- *WuXi PharmaTech** (Cayman) Inc.* (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial re...
WuXi PharmaTech Schedules Third-Quarter 2011 Earnings Release
SHANGHAI, Oct. 25, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the third quarter o...
WuXi PharmaTech Acquires China-Based Clinical Research Services Companies
SHANGHAI, Oct. 24, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development services company with operations in China and the United States, today announced the acquisition of MedKey Med-Tech Development C...
WuXi PharmaTech Acquires Abgent, a Leading Producer of Biological Research Reagents
SHANGHAI, Oct. 13, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development services company with operations in China and the United States, today announced the acquisition of Abgent, Inc., a provider of b...
WuXi PharmaTech Announces Resignation of Board Member Cuong Viet Do
SHANGHAI, Sept. 30, 2011 /PRNewswire-Asia/ --WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that Cuong Viet Do is stepping down from WuXi's board of directors effective immediately. Mr. Do has been appointed Chief Strategy Officer of Merck and Company, which is a large WuXi customer. "I ...
WuXi PharmaTech Announces Second Quarter 2011 Results
SHANGHAI, Aug. 10, 2011 /PRNewswire-Asia/ -- *WuXi PharmaTech** (Cayman) Inc.* (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial re...
WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
SHANGHAI, Aug. 9, 2011 /PRNewswire-Asia/ -- *WuXi PharmaTech (Cayman) Inc.* (NYSE: WX) today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on August 9, 2011. At the meeting, WuXi PharmaTech shareholders approved the re-election of incumben...
WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release
SHANGHAI, July 19, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter ...
WuXi AppTec Named a Top Ten Chinese Outsourcing Enterprise
Dr. Ge Li, Chairman and CEO, Named a Top Ten Contributor to China's Outsourcing Industry SHANGHAI, June 16, 2011 /PRNewswire-Asia/ -- WuXi AppTec announced today that it has been selected as one of the Top Ten Outsourcing Enterprises in China for 2011 by China's Ministry of Commerce. The list was...
WuXi PharmaTech Announces First-Quarter 2011 Results
SHANGHAI, May 11, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results...
WuXi PharmaTech Files 2010 Annual Report on Form 20-F
SHANGHAI, April 27, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2010 with the Securities and Exchange Commission. The annual report can be accessed on WuXi PharmaTech's website at http...
WuXi PharmaTech Schedules First-Quarter 2011 Earnings Release
SHANGHAI, April 20, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the first quarter of 2...
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2010 Results
SHANGHAI, March 9, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial result...
